drugset / Trial / NCT05082285
A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the safety, tolerability and immunogenicity of the combined meningococcal groups A, B, C, W and Y (MenACWY-7b) vaccine intended to protect against invasive meningococcal disease (IMD) caused by all 5 meningococcal serogroups, in healthy infants 2 months of age (MoA) at enrolment.
Timeline
- Start
- 2021-11-29
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MenABCWY-1Gen | Vaccine | — | Intramuscular |
| Subject | MenACWY-7B | Vaccine | — | Intramuscular |
| Subject | MenB | Vaccine | — | Intramuscular |
| Subject | Menveo | Vaccine | — | Intramuscular |